ALBEMARLE LITHIUM HOLDING CORPORATION – Trademark Portfolio
Entity Type: 03
ALBEMARLE LITHIUM HOLDING CORPORATION holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 1 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PERMATREAT. The owner is based in NEW PROVIDENCE, NJ.
675 CENTRAL AVENUE
NEW PROVIDENCE, NJ 07974
Showing of trademarks Trademarks
Trademark Classifications
ALBEMARLE LITHIUM HOLDING CORPORATION's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Frequently Asked Questions
How many trademarks does ALBEMARLE LITHIUM HOLDING CORPORATION have?
ALBEMARLE LITHIUM HOLDING CORPORATION has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does ALBEMARLE LITHIUM HOLDING CORPORATION file in?
ALBEMARLE LITHIUM HOLDING CORPORATION files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are ALBEMARLE LITHIUM HOLDING CORPORATION's most well-known trademarks?
ALBEMARLE LITHIUM HOLDING CORPORATION's registered trademark portfolio includes well-known marks such as PERMATREAT. These are among 1 currently registered trademark in the portfolio.
What is ALBEMARLE LITHIUM HOLDING CORPORATION's trademark registration success rate?
ALBEMARLE LITHIUM HOLDING CORPORATION has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.